Aruba vs Jordan: Tuberculosis patients living with HIV receiving antiretroviral therapy
Aruba
0 patients
in 2021
Jordan
0 patients
in 2021
Aruba rank
141st
Jordan rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Aruba
- Jordan
How they compare
Aruba currently reports 0 patients against 0 patients in Jordan, a difference of 0 patients.
The two have swapped places 1 time across 5 shared years of data; in 2012 it was Aruba ahead.
Aruba ranks 141st and Jordan ranks 141st of 183 countries.
Aruba has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Aruba | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3333 patients | 0 patients | 0.3333 patients | Aruba |
| 2020s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Aruba or Jordan?
- Aruba, at 0 patients against 0 patients in Jordan as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Aruba and Jordan?
- 0 patients, with Aruba ahead.
- How many years of comparable data are there for Aruba and Jordan?
- 5 years are reported by both, from 2012 to 2021.
- How do Aruba and Jordan rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Aruba ranks 141st and Jordan ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.